Effects of 25-hydroxyvitamin D on Bone Microstructure in T2MD Rats

Overview

Journal J Musculoskelet Neuronal Interact

Specialties Neurology
Orthopedics
Physiology

Date 2018 Dec 5

PMID 30511956

Authors

Junbo Ge

Dongning Sun

Lili Teng

Baifang Su

Xinqing Niu

Wenming Luo

Affiliations

Soon will be listed here.

Abstract

Objective: This study aims to explore the effects of 25-hydroxyvitamin D on the bone microstructure of rats with type 2 diabetes mellitus (T2MD).

Methods: 40 male Wistar rats were randomly selected for T2MD modeling and injected with streptozotocin solution. The rats in the control group (n=19) were fed with common feed. 25-hydroxyvitamin D was injected into rats with successful modeling results (Treatment group, n=15). The remaining rats were considered as the model group (n=16). The enzyme-linked immunosorbent assay was adopted to determine bone gla protein (BGP) and tartrate-resistant acid phosphatase (TRACP), and an X-ray bone densitometer were applied to observe the vertebral sections.

Results: The activity levels of blood glucose, triglyceride, total cholesterol and TRACP in the model group were higher than those in the treatment group and the control group (p⟨0.01), while serum calcium, phosphorus, BGP, ALP, and glycosylated hemoglobin, various indicators of rats in the model group were lower than those in the treatment group and the control group (p⟨0.05).

Conclusions: It is feasible to treat rats with T2MD with 25-hydroxyvitamin D, which can maintain the integrity of bone microstructure and increase the bone health.

References

Rutter G, Pullen T, Hodson D, Martinez-Sanchez A . Pancreatic β-cell identity, glucose sensing and the control of insulin secretion. Biochem J. 2015; 466(2):203-18. DOI: 10.1042/BJ20141384. View

Tangvarasittichai S . Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015; 6(3):456-80. PMC: 4398902. DOI: 10.4239/wjd.v6.i3.456. View

Wang Z, Li H, Zhang D, Liu X, Zhao F, Pang X . Effect of advanced glycosylation end products on apoptosis in human adipose tissue-derived stem cells in vitro. Cell Biosci. 2015; 5:3. PMC: 4429817. DOI: 10.1186/2045-3701-5-3. View

Meng H, Zhang W, Liu F, Yang M . Advanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase.... J Biol Chem. 2015; 290(47):28189-28199. PMC: 4653677. DOI: 10.1074/jbc.M115.669499. View

Reid I . Short-term and long-term effects of osteoporosis therapies. Nat Rev Endocrinol. 2015; 11(7):418-28. DOI: 10.1038/nrendo.2015.71. View

Zhen D, Liu L, Guan C, Zhao N, Tang X . High prevalence of vitamin D deficiency among middle-aged and elderly individuals in northwestern China: its relationship to osteoporosis and lifestyle factors. Bone. 2014; 71:1-6. DOI: 10.1016/j.bone.2014.09.024. View

Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M . Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2014; 38(1):140-9. DOI: 10.2337/dc14-2441. View

Jia G, Demarco V, Sowers J . Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2015; 12(3):144-53. PMC: 4753054. DOI: 10.1038/nrendo.2015.216. View

FAJANS S, FLOYD Jr J, Knopf R, Conn F . Effect of amino acids and proteins on insulin secretion in man. Recent Prog Horm Res. 1967; 23:617-62. DOI: 10.1016/b978-1-4831-9826-2.50017-9. View

10.

Khunti K, Davies M, Majeed A, Thorsted B, Wolden M, Paul S . Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care. 2014; 38(2):316-22. DOI: 10.2337/dc14-0920. View

11.

Clemente-Postigo M, Munoz-Garach A, Serrano M, Garrido-Sanchez L, Bernal-Lopez M, Fernandez-Garcia D . Serum 25-hydroxyvitamin D and adipose tissue vitamin D receptor gene expression: relationship with obesity and type 2 diabetes. J Clin Endocrinol Metab. 2015; 100(4):E591-5. DOI: 10.1210/jc.2014-3016. View

12.

Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U . Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab. 2015; 26(4):193-200. DOI: 10.1016/j.tem.2015.01.006. View

13.

Fox C, Golden S, Anderson C, Bray G, Burke L, de Boer I . Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation. 2015; 132(8):691-718. PMC: 9728095. DOI: 10.1161/CIR.0000000000000230. View

14.

Abdalrahaman N, McComb C, Foster J, McLean J, Lindsay R, McClure J . Deficits in Trabecular Bone Microarchitecture in Young Women With Type 1 Diabetes Mellitus. J Bone Miner Res. 2015; 30(8):1386-93. DOI: 10.1002/jbmr.2465. View

15.

Carmeliet G, Dermauw V, Bouillon R . Vitamin D signaling in calcium and bone homeostasis: a delicate balance. Best Pract Res Clin Endocrinol Metab. 2015; 29(4):621-31. DOI: 10.1016/j.beem.2015.06.001. View

16.

Callegari E, Reavley N, Garland S, Gorelik A, Wark J . Vitamin D Status, Bone Mineral Density and Mental Health in Young Australian Women: The Safe-D Study. J Public Health Res. 2016; 4(3):594. PMC: 4693343. DOI: 10.4081/jphr.2015.594. View

17.

Harre U, Lang S, Pfeifle R, Rombouts Y, Fruhbeisser S, Amara K . Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat Commun. 2015; 6:6651. PMC: 4389255. DOI: 10.1038/ncomms7651. View

18.

Cashman K, Dowling K, Skrabakova Z, Gonzalez-Gross M, Valtuena J, de Henauw S . Vitamin D deficiency in Europe: pandemic?. Am J Clin Nutr. 2016; 103(4):1033-44. PMC: 5527850. DOI: 10.3945/ajcn.115.120873. View